Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-20
1990-10-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3141
Patent
active
049669095
ABSTRACT:
The invention relates to 4-benzyl-5-phenyl-1,2,4-dihydro-3H-1,2,4-triazol-3-ones and to their use as anticonvulsants for treatment of seizure disorders.
REFERENCES:
patent: 4414221 (1983-11-01), Parsons et al.
M. M. Shemyakin, et al., Tetrahedron 27 2811-2820 (1971).
Chemical Abstracts 75:88541j. (Syeda Husain, et al., Indian J. Chem., 9(7) 642-6 (1971).
F. P. Miller, et al., FASEB J. 2, A1070, Abstract 4501 (1988).
G. Maffii, et al., Studio Farmacologico Di Alcuni Ossadiazoli E Triazoli, Farmaco 13, 629-38 (1958).
Kane John M.
Miller Francis P.
Friedman Stanley J.
Merrell Dow Pharmaceuticals
Simmons Edlyn S.
LandOfFree
4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-275469